Reaction

Cerebellar Atrophy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 873 reports · 22 co-occurring drugs

As of the last recalculation, Cerebellar Atrophy appears in 873 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is EXTENDED PHENYTOIN SODIUM (PRR 205.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Extended Phenytoin Sodium124205.8207.3
Phenytoin144196.8198.2
Phenobarbital3559.960.1
Primidone2047.948.0
Valproic Acid5140.941.0
Lithium3736.536.5
Lithium Bromatum3736.536.5
Lithium Carbonate2333.133.2
Clobazam3232.432.4
Valproate Sodium2529.729.7
Zonisamide1626.226.3
Lacosamide2919.219.2
Divalproex Sodium3518.618.7
Rivastigmine1418.018.0
Carbamazepine4516.816.8
Levetiracetam8115.815.8
Oxcarbazepine2115.815.8
Levetiracetam In Sodium Chloride4614.914.9
Levetiracetam Oral4614.914.9
Levetiracetam Injection4614.914.9
Norepinephrine511.211.2
Paliperidone77.27.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.